Oncolytics Biotech Inc. (ONCY) Stock Plunges Despite Positive Results from Phase 2 Breast Cancer Trial
Promising findings from the BRACELET-1 trial fail to uplift investor confidence On May 26th, Oncolytics Biotech Inc. (NASDAQ: ONCY) experienced […]
